Ombudsman’s Annual Report for 2008 FDA, Center for Drug Evaluation and Research (CDER) The CDER Ombudsman’s Office houses both the CDER Ombudsman, Virginia L. Behr, and CDER’s Product Jurisdiction Officer, LCDR Ayo

First Page		Document Content
Health Clinical pharmacology Pharmaceutical industry Pharmacy Center for Drug Evaluation and Research Ombudsman Generic drug Investigational New Drug Drug discovery Pharmaceutical sciences Pharmacology Food and Drug Administration		Ombudsman’s Annual Report for 2008 FDA, Center for Drug Evaluation and Research (CDER) The CDER Ombudsman’s Office houses both the CDER Ombudsman, Virginia L. Behr, and CDER’s Product Jurisdiction Officer, LCDR Ayo Add to Reading List Source URL: www.fda.gov Download Document from Source Website File Size: 53,49 KB Share Document on Facebook

	Rapid, automated immunoassay for atazanavir in plasma and cerebrospinal fluid (CSF) using the ARK ATV-TestTM Michael K. Helms, PhD, MBA ARK Diagnostics, Inc. 7th International Workshop on Clinical Pharmacology of HIV The DocID: 1viL6 - View Document
	Epilepsy Research Group Clinical pharmacology of antiepileptic drugs Challenges To improve our knowledge for better antiepileptic drug treatment of the individual patient. Pharmacoepidemiological studies of antiepileptic DocID: 1uXCJ - View Document
	APPLICATION FOR ACCREDITATION OF A CLINICAL PHARMACOLOGY FELLOWSHIP PROGRAM Send completed application, electronic copies (email or CD) of all documents and fee to: DocID: 1ux80 - View Document
	Clinical pharmacology and Pharmacogenomics Challenges Patients respond highly variably to drug therapy. The reason may be pharmacokinetic and/or pharmacodynamic differences between patients, due to differences in metabol DocID: 1uw1R - View Document
	Penn State University Youth Program Health Services Medical Treatment Authorization This form must be completed and returned before youth camp/program/event enrollment dates in order for youth to be permitted to particip DocID: 1rtZA - View Document